Show simple item record

dc.contributor.authorYALÇIN, ŞUAYİB
dc.contributor.authorÖZKAN, METİN
dc.contributor.authorSevinc, Alper
dc.contributor.authorBasaran, Mert
dc.contributor.authorCoskun, Ugur
dc.contributor.authorERMAN, MUSTAFA
dc.contributor.authorBENEKLİ, MUSTAFA
dc.contributor.authorBavbek, Sevil
dc.contributor.authorBuyukberber, Suleyman
dc.contributor.authorDemir, Gokhan
dc.contributor.authorKARABULUT, BÜLENT
dc.contributor.authorOksuzoglu, Berna
dc.date.accessioned2021-03-03T07:50:31Z
dc.date.available2021-03-03T07:50:31Z
dc.date.issued2016
dc.identifier.citationERMAN M., BENEKLİ M., Basaran M., Bavbek S., Buyukberber S., Coskun U., Demir G., KARABULUT B., Oksuzoglu B., ÖZKAN M., et al., "Renal cell cancer: overview of the current therapeutic landscape", EXPERT REVIEW OF ANTICANCER THERAPY, cilt.16, sa.9, ss.955-968, 2016
dc.identifier.issn1473-7140
dc.identifier.otherav_1434741b-bcfc-431d-af31-fa0a939522bd
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/18981
dc.identifier.urihttps://doi.org/10.1080/14737140.2016.1222908
dc.description.abstractIntroduction: The last decade has witnessed dramatic improvements in the diagnosis, classification and treatment of renal cell cancer (RCC). Besides improvements in surgical techniques in early stages, introduction of novel targeted agents has resulted in improved outcomes in advanced RCC for which no effective treatment existed until recently.Areas covered: This article reviews epidemiology, pathology and pathogenesis, diagnosis, clinical staging, prognostic factors and treatment modalities of early stage and advanced RCC.Expert commentary: Although treatment options are expanding rapidly, practicing physicians face considerable challenges in the decision-making process. Therapeutic agents may have unique side effects and unexpected drug interactions. RCC represents one of the major success stories of clinical oncology in recent years and the progress appears to be far from having reached a plateau. We aim to present a comprehensive in-depth review of RCC in an attempt to provide evidence-based recommendations and future perspectives for practicing oncologists.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectOnkoloji
dc.titleRenal cell cancer: overview of the current therapeutic landscape
dc.typeMakale
dc.relation.journalEXPERT REVIEW OF ANTICANCER THERAPY
dc.contributor.departmentHacettepe Üniversitesi , Kanser Enstitüsü ,
dc.identifier.volume16
dc.identifier.issue9
dc.identifier.startpage955
dc.identifier.endpage968
dc.contributor.firstauthorID235080


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record